Treatment of an Infant Under 8 Months with Kawasaki Disease and Reye's Syndrome
Critical Management Decision
In an infant under 8 months presenting with both Kawasaki disease and Reye's syndrome, aspirin must be immediately discontinued and IVIG 2 g/kg should be administered as a single infusion without aspirin, while managing Reye's syndrome with supportive intensive care. 1
Immediate Actions for Dual Diagnosis
Discontinue Aspirin Immediately
- Stop all salicylate therapy immediately upon recognition of Reye's syndrome, as aspirin is a known contributing factor to this metabolic disorder 1, 2
- Reye's syndrome has been documented in infants as young as 7-10 months receiving high-dose aspirin for Kawasaki disease, with rapid progression to hepatic failure and encephalopathy 2, 3
Administer IVIG Without Aspirin
- Proceed with IVIG 2 g/kg as a single infusion over 10-12 hours as the primary treatment for Kawasaki disease, which remains effective without concurrent aspirin therapy 1, 4
- The American Heart Association explicitly addresses this scenario, recommending IVIG administration without aspirin when influenza or other viral infections complicate Kawasaki disease 1
Intensive Care Management for Reye's Syndrome
- Transfer to intensive care unit for management of hepatic encephalopathy, coagulopathy, and hyperammonemia 2, 3
- Monitor for hypoglycemia, elevated transaminases (AST/ALT), prolonged PT/PTT, and elevated ammonia levels 2, 3
- Provide supportive care including glucose supplementation, correction of coagulopathy, and management of increased intracranial pressure 2, 3
Alternative Antipyretic and Antiplatelet Strategy
Fever Management
- Use acetaminophen as the alternative antipyretic during the acute phase instead of aspirin 1
- Continue acetaminophen until fever resolves for 48-72 hours 1
Antiplatelet Therapy After Reye's Syndrome Resolution
- Substitute an alternative antiplatelet agent for a minimum of 2 weeks once Reye's syndrome resolves and if antiplatelet therapy is needed 1
- Consider clopidogrel as the alternative antiplatelet agent if coronary abnormalities develop 5, 4
- Do not resume aspirin therapy until the infant has fully recovered from Reye's syndrome and viral illness has completely resolved 1
Cardiac Monitoring Protocol
Echocardiographic Surveillance
- Perform echocardiography at diagnosis, 2 weeks, and 6-8 weeks after treatment initiation 4
- Infants under 1 year have the highest risk of coronary artery aneurysms, making aggressive monitoring essential 4, 6
Long-Term Anticoagulation Based on Coronary Status
- If no coronary abnormalities develop by 6-8 weeks, discontinue antiplatelet therapy entirely 1, 4
- If coronary abnormalities develop, continue alternative antiplatelet agent (clopidogrel) indefinitely rather than aspirin given the history of Reye's syndrome 1, 4
- For giant aneurysms (≥8 mm), add warfarin with target INR 2.0-3.0 or low molecular weight heparin 5, 4
Critical Pitfalls to Avoid
Do Not Resume Aspirin Prematurely
- Never restart aspirin while any viral illness symptoms persist or within 2 weeks of Reye's syndrome diagnosis, as recurrence risk remains elevated 1, 7
- The mortality rate from Reye's syndrome in infants can be extremely high (case reports document death within 2 days despite intensive care) 3
Do Not Delay IVIG Waiting for Aspirin
- IVIG alone is effective for preventing coronary artery abnormalities; aspirin does not reduce coronary complications and serves only as adjunctive anti-inflammatory and antiplatelet therapy 1, 4
- Delaying IVIG to address aspirin concerns increases risk of coronary artery aneurysms, which occur in 20-25% of untreated patients 6
Recognize Reye's Syndrome Early
- In infants, Reye's syndrome may present more subtly with diarrhea, respiratory disturbances, and seizures rather than the classic protracted vomiting seen in older children 8
- Symptoms typically develop 3-5 days after aspirin initiation, just when the child appears to be recovering from the acute illness 8, 3
Future Prevention Strategies
Influenza Vaccination
- Once the infant reaches 6 months of age and recovers, administer annual inactivated influenza vaccine to prevent future viral triggers for Reye's syndrome 1, 7, 4
- Vaccinate all family members to reduce household transmission risk 1, 4